Polypharmacy in Patients Discharged from Oncology Department |
Bae, Hyunjin
(Department of Pharmacy, Seoul National University Hospital)
Hahn, Jimin (Department of Pharmacy, Seoul National University Hospital) Lee, Yong Hwa (Department of Pharmacy, Seoul National University Hospital) Kim, Hyangsook (Department of Pharmacy, Seoul National University Hospital) Lee, Hye Suk (Department of Pharmacy, Seoul National University Hospital) Lee, Se-Hoon (Department of Internal Medicine, Seoul National University Hospital) Heo, Dae Seog (Department of Internal Medicine, Seoul National University Hospital) Lee, Juyeun (College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University) |
1 | Cancer research U.K Demographic facts for the world population. http://info.cancerresearchik.org/cancerstats/world/ demographics/index.htm. |
2 | Lees J, Chan A. Polypharmacy in elderly patients with cancer: clinical implications and management. Lancet Oncol 2011; 12: 1249-57. DOI |
3 | Puts MT, Costa-Lima B, Monette J, et al., Medication problems in older, newly diagnosed cancer patients in Canada: how common are they? A prospective pilot study. Drugs Aging 2009; 26: 519-536. DOI |
4 | Hanigan MH, Dela Cruz BL, Thompson DM, et al., Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: questionnaire validation. J Oncol Pharm Pract 2008; 14: 123-130. DOI |
5 | Riechelmann RP, Tannock IF, Wang L, et al., Potential Drug Interactions and Duplicate Prescriptions Among Cancer Patients. J Natl Cancer Inst. 2007; 99: 592-600. DOI |
6 | Micromedex Drugdex (TM) (Thomson, Green wood, co, USA) |
7 | Cashman J, Wright J, Ring A. The treatment of comorbidities in older patients with metastatic cancer. Support Care Cancer 2010; 18: 651-655. DOI |
8 | Koh Y, Kutty FB, Li SC. Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag 2005; 1(1): 39-48. DOI |
9 | Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001; 23(8): 1296-1310. DOI |
10 | Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf 2007; 30(10): 911-918. DOI |
11 | Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review J Am Acad Nurse Pract 2005; 17: 123-132. DOI |
12 | Goldberg RM, Mabee J, Chan L, et al., Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med 1996; 14(5): 447-450. |
13 | Maggiore RH, Gross CP, Hurria A. Polypharmacy in older adults with cancer. Oncologist 2010; 15: 507-522. DOI |
14 | JY Lee, KH Choi, YS Cho, et al., The Benefit of Pharmacists' intervention on self-medications and discharge orders in the cardiology ward. J Kor Soc Health-Syst Pharm 2009; 26 (4): 356-361. |
15 | Yap KY, Kuo EY, Lee JJ, et al., An onco-infomatics database for anticancer drug interactions with complementary and alternative medicines used in cancer treatment and supportive care: an overview of the OncoRx project, Support Care Cancer 2009; 10: 1011-1019. |
16 | Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 2008; 42: 1017-1025. DOI |
17 | Lee HJ, Kang MK, Ko JH, et al., Analysis of Chemotherapy Prescribing Errors Detected by Pharmacists. Kor J Clin Pharm 2010; 20(2): 120-7. |
18 | Joo EH, Joh HN, Seo SM, et al., Survery on the Polypharmacy for the Outpatients in General Hospital. J Kor Soc Health-Syst Pharm 1997; 14(2): 129-134. |
19 | National Prescribing Service Limited and Palliative Care Australia. Achieving quality use of medicines in the community for palliative and end of life care: A consultation report. Sydney: National Prescribing Service Ltd, 2009. |
20 | C R Goh. Minimising Polypharmacy-a Challenge in Palliative Care. Singapore Med J 2002; 43(6): 273-275. |
21 | Koh NY, Koo WH. Polypharmacy in palliative care: can it be reduced? Singapore Med J 2002; 43(6): 279-283. |